去心房颤动市场规模、份额、成长分析（按类型、患者类型、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，去心房颤动市场规模将达到 163.2 亿美元，到 2025 年将达到 176.4 亿美元，到 2033 年将达到 329 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.1%。

去心房颤动市场正经历显着成长，这主要得益于技术进步、心臟麻痹率上升以及公众意识提升的提高。政府和医疗保健机构的措施在促进去心房颤动的广泛使用和普及方面也发挥关键作用。家用个人体外心臟去心房颤动（AED）等创新产品正在拓展市场机会。儘管目前已采取预防措施，但心臟麻痹仍然是心血管死亡的主要原因之一，这表明植入式心臟整流去颤器（ICD）和体外去心房颤动器（AED）的需求量很大。尤其是在发展中国家，公众意识的不断提高，以及旨在促进心臟健康和改进培训计画的区域性倡议，进一步推动了市场扩张。主要企业正在提供多样化的产品系列以满足不同环境的需求，从而巩固其市场地位并推动收入成长。

去心房颤动市场驱动因素

全球去心房颤动市场的主要驱动因素之一是心血管疾病的日益流行，心血管疾病是全球首要死因。随着人口老化和久坐生活方式的盛行，心律不整和心臟麻痹等心臟相关疾病的发生率显着上升。这一日益严重的健康问题促使人们更加关注并需要先进的医疗干预措施，包括在医院、紧急应变系统和公共场所部署去心房颤动。此外，技术的不断进步，例如携带式和用户友好型设备的开发，提高了紧急情况下除颤器的可及性和有效性，进一步推动了市场扩张。

去心房颤动市场的限制

全球去心房颤动市场的主要限制因素之一是先进去心房颤动设备及其相关培训项目的高成本。由于预算限制，许多医疗机构，尤其是在中低收入地区，可能难以负担先进去心房颤动的投资。此外，医护人员需要持续接受训练才能有效使用这些设备，这进一步加重了经济负担，并限制了这项关键救生技术的普及。这种经济障碍可能会阻碍去心房颤动的广泛应用，尤其是在医疗资源匮乏的地区，最终影响严重心臟疾病患者的治疗效果。

去心房颤动市场趋势

去心房颤动市场正呈现显着的成长趋势，这主要得益于技术的快速进步，这些进步提升了设备的效能和使用者体验。人工智慧演算法等创新技术正被整合到除颤器中，以提高心率检测的准确性，从而实现更快、更有效的治疗。此外，无线连接正逐渐成为标准配置，方便远端监控和资料无缝传输至医疗服务提供者。操作更直觉的改良型使用者介面也正在涌现，使这些救生设备更容易被一般民众和医疗专业人员所使用。这些进步的共同作用有望改善患者的治疗效果，并推动医疗保健行业的市场成长。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究
• 专利分析

全球去心房颤动市场规模（按类型及复合年增长率划分）（2026-2033 年）

• 植入式心臟整流去颤器
  • 经静脉植入式心臟整流去颤器
  • 植入式植入式去心房颤动
• 体外去心房颤动
  • 手动和半自动体外去心房颤动
  • 全自动体外心臟去心房颤动
  • 穿戴式去心房颤动

全球去心房颤动市场规模（依病患类型划分）及复合年增长率（2026-2033 年）

• 成人版
• 儿童

全球去心房颤动市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 医院、诊所和心臟中心
• 院前医疗环境
• 公共准入市场
• 居家医疗环境
• 替代医疗设施
• 其他最终用户

全球去心房颤动市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Medtronic（Ireland）
• Abbott Laboratories（USA）
• Boston Scientific Corporation（USA）
• Koninklijke Philips NV（Netherlands）
• ZOLL Medical Corporation（Asahi Kasei）（USA/Japan）
• Nihon Kohden Corporation（Japan）
• Stryker（USA）
• BIOTRONIK SE & Co. KG（Germany）
• MicroPort Scientific Corporation（China）
• Schiller AG（Switzerland）
• Mindray Medical International Ltd.（China）
• Defibtech LLC（USA）
• LivaNova PLC（UK）
• Cardiac Science Corporation（USA）
• Bexen Cardio（Spain）
• Physio-Control Inc.（USA）
• CU Medical Systems Co., Ltd.（South Korea）
• Metrax GmbH（Germany）
• BPL Medical Technologies（India）
• Avive Solutions Inc.（USA）

结论与建议

Defibrillator Market size was valued at USD 16.32 Billion in 2024 and is poised to grow from USD 17.64 Billion in 2025 to USD 32.9 Billion by 2033, growing at a CAGR of 8.1% during the forecast period (2026-2033).

The defibrillator market is experiencing significant growth driven by advancements in technology, rising occurrences of sudden cardiac arrest, and heightened public awareness. Government and healthcare initiatives are also playing a vital role in promoting defibrillator accessibility and use. Innovations such as personal AEDs, which allow for home use, are expanding market opportunities. Despite current preventive measures, sudden cardiac arrest remains a leading cause of cardiovascular mortality, underscoring the demand for both implantable cardioverter defibrillators (ICDs) and external defibrillators. Increasing awareness, especially in developing markets, further propels market expansion, supported by local initiatives aimed at enhancing cardiac health and training programs. Leading companies demonstrate diverse product offerings to cater to various settings, reinforcing their market presence and driving revenue growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Defibrillator market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Defibrillator Market Segments Analysis

Global Defibrillator Market is segmented by Type, Patients type, End Users and region. Based on Type, the market is segmented into Implantable cardioverter defibrillators and External defibrillators. Based on Patients type, the market is segmented into Adult and Pediatrics. Based on End Users, the market is segmented into Hospitals, Clinics and Cardiac centres, Pre-hospital care settings, Public access markets, Home care settings, Alternate care facilities and Other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Defibrillator Market

One of the key market drivers for the global defibrillator market is the increasing prevalence of cardiovascular diseases, which are a leading cause of mortality worldwide. As the population ages and lifestyles become more sedentary, the incidence of heart-related conditions such as arrhythmias and sudden cardiac arrest rises significantly. This growing health concern has led to heightened awareness and demand for advanced medical interventions, including the deployment of defibrillators in hospitals, emergency response systems, and public spaces. Moreover, ongoing advancements in technology, such as the development of portable and user-friendly devices, further bolster market expansion by enhancing accessibility and effectiveness in emergency situations.

Restraints in the Defibrillator Market

One key market restraint for the global defibrillator market is the high cost associated with advanced defibrillation devices and related training programs. Many healthcare facilities, particularly in low- to middle-income regions, may find it economically challenging to invest in sophisticated defibrillators due to budget constraints. Additionally, the requirement for ongoing training for medical personnel to effectively use these devices further exacerbates financial burdens, limiting access to essential life-saving technology. This financial barrier can hinder the widespread adoption of defibrillators, particularly in underserved areas, ultimately impacting patient outcomes in critical cardiac situations.

Market Trends of the Defibrillator Market

The defibrillator market is experiencing a significant upward trend fueled by rapid technological advancements that enhance device performance and user experience. Innovations such as artificial intelligence algorithms are being integrated to improve the accuracy of cardiac rhythm detection, enabling faster and more effective interventions. Additionally, wireless connectivity is becoming a standard feature, facilitating remote monitoring and seamless data transmission to healthcare providers. Enhanced user interfaces, designed for intuitive operation, are also emerging, making these life-saving devices more accessible to laypersons and healthcare professionals alike. Collectively, these advancements are poised to improve patient outcomes and drive market growth in the healthcare sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Patent Analysis

Global Defibrillator Market Size by Type & CAGR (2026-2033)

• Market Overview
• Implantable cardioverter defibrillators
  • Transvenous implantable cardioverter defibrillators
  • Subcutaneous implantable cardioverter defibrillators
• External defibrillators
  • Manual & semi-automated external defibrillators
  • Fully automated external defibrillators
  • Wearable cardioverter defibrillators

Global Defibrillator Market Size by Patients type & CAGR (2026-2033)

• Market Overview
• Adult
• Pediatrics

Global Defibrillator Market Size by End Users & CAGR (2026-2033)

• Market Overview
• Hospitals, Clinics and Cardiac centres
• Pre-hospital care settings
• Public access markets
• Home care settings
• Alternate care facilities
• Other end users

Global Defibrillator Market Size & CAGR (2026-2033)

• North America (Type, Patients type, End Users)
  • US
  • Canada
• Europe (Type, Patients type, End Users)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Patients type, End Users)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Patients type, End Users)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Patients type, End Users)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZOLL Medical Corporation (Asahi Kasei) (USA/Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BIOTRONIK SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MicroPort Scientific Corporation (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Schiller AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Defibtech LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardiac Science Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bexen Cardio (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Physio-Control Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CU Medical Systems Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrax GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPL Medical Technologies (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avive Solutions Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations